Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Target

tumor-directed immune responses

1 abstract

Abstract
Phase 1/2 randomized, open-label, multicenter, Simon two-stage study of pelareorep combined with modified FOLFIRINOX +/- atezolizumab in patients with metastatic pancreatic ductal adenocarcinoma.
Org: Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, AK Altona, Asklepios Tumourzentrum Hamburg, Oncolytics Biotech, Calgary, AB, Canada,